Role of Plasma Proteins in Pharmacokinetics of Micafungin, an Antifungal Antibiotic, in Analbuminemic Rats

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

There were no significant differences in the pharmacokinetics of micafungin and expression of hepatic multidrug resistance-associated protein 2 (ABCC2/Mrp2) between analbuminemic and Sprague-Dawley rats. Micafungin bound strongly to high-density lipoprotein (HDL) and moderately to gamma globulin. These results suggest that HDL and gamma globulin contribute to the pharmacokinetics of micafungin.

DOI： 10.1128/aac.00396-08

Knowledge Graph

Similar Paper

Role of Plasma Proteins in Pharmacokinetics of Micafungin, an Antifungal Antibiotic, in Analbuminemic Rats
Antimicrobial Agents and Chemotherapy 2008.0
Effects of Serum on In Vitro Susceptibility Testing of Echinocandins
Antimicrobial Agents and Chemotherapy 2007.0
Antifungal Activity of Micafungin in Serum
Antimicrobial Agents and Chemotherapy 2009.0
Identification, Characterization, and Implications of Species-Dependent Plasma Protein Binding for the Oral Hedgehog Pathway Inhibitor Vismodegib (GDC-0449)
Journal of Medicinal Chemistry 2011.0
Pharmacokinetics and Tissue Distribution of Anidulafungin in Rats
Antimicrobial Agents and Chemotherapy 2008.0
Bronchopulmonary Disposition of Micafungin in Healthy Adult Volunteers
Antimicrobial Agents and Chemotherapy 2009.0
Population Pharmacokinetics of Micafungin in Neonates and Young Infants
Antimicrobial Agents and Chemotherapy 2010.0
None
None nan
Species differences in drug plasma protein binding
Med. Chem. Commun. 2014.0
Selective plasma protein binding of antimalarial drugs to α1-acid glycoprotein
Bioorganic & Medicinal Chemistry 2008.0